::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY OF VARIOUS MICROORGANISMS IN PATIENTS OF EMPYEMA THORACIS, DEVELOPING AS A COMPLICATION OF BACTERIAL PNEUMONIA

AUTHORS:

Dr. Aizaz Rafiq Chaudhry, Dr. Mariam Shah, Dr. Rana Ali Assadullah

ABSTRACT:

Objective: To study the various microorganisms in patients of empyema thoracis developing as a complication of bacterial pneumonia. Material and methods: This cross-sectional study was conducted at Bahawal Victoria Hospital, Bahawalpur form May 2019 to November 2019 over the period of 6 months. In this study, 102 patients with empyema thoracis were included. Aspirate from pleural cavity was sent for culture and sensitivity. The main outcome variable was frequency of microorganisms detected in culture and sensitivity reports which were described as frequency distribution tables. Results: Out of 102 patients, growth was seen among 79 (77.5%) patients. Out of those 79 patients, the following were results: streptococcus milleri in 26 (32.9%) patients, Klebsiella pneumoniae in 19 (24.1%) patients and bacterioides in 12 (15.1%) patients. Conclusion: Streptococcus milleri is the most common causative microorganism detected in patients with empyema throacis. Key Words: Empyema thoracis, bacterial pneumonia, microorganisms